TrialCancer research2011

Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.

Li Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.